Missouri Patent of the Month – May 2024

UNandUP, LLC builds technologies and solutions for Unmet Needs & Underserved Populations. Their focus is on overcoming healthcare needs with magnetic therapeutic and robotic solutions. Recently, the company was granted a patent for a method of making magnetically controllable devices for interventional medical procedures. 

This technology stands out by incorporating magnetic materials without permanent magnetization during manufacturing, which are later magnetized using a specialized magnet array. This post-manufacturing magnetization technique provides precise control over the medical device, allowing different segments to have distinct magnetic orientations, strengths, and angles.

The implications of this technology are profound for interventional procedures. By utilizing materials like platinum cobalt (PtCo) or other platinum and palladium alloys, these devices—ranging from guidewires to catheters—can navigate the complex and tortuous pathways within the body with unprecedented accuracy and ease. This advancement is particularly significant in procedures like thrombectomies for acute ischemic strokes, where time and precision are critical.

Magnetically controlled medical devices offer a solution to the limitations of manual and robotic navigation systems. Traditional manual systems struggle with the inefficiency of force transmission over long distances, while existing robotic platforms are often prohibitively expensive and bulky. UNandUP’s innovation addresses these issues by enabling smaller, more agile devices to be magnetically guided with high precision, potentially reducing procedure times, exposure to radiation, and improving patient outcomes.

This technology promises to democratize access to high-quality medical interventions. By enabling remote guidance of these devices, highly skilled neuro-interventionists can assist in procedures regardless of their physical location, expanding the reach of comprehensive stroke centers and improving the timeliness of care for patients in underserved areas. This leap in medical technology not only enhances procedural success rates but also bridges the gap in healthcare accessibility, ensuring that advanced medical care is within reach for more patients.

Are you developing new technology for an existing application? Did you know your development work could be eligible for the R&D Tax Credit and you can receive up to 14% back on your expenses? Even if your development isn’t successful your work may still qualify for R&D credits (i.e. you don’t need to have a patent to qualify). To find out more, please contact a Swanson Reed R&D Specialist today or check out our free online eligibility test.

Who We Are:

Swanson Reed is one of the U.S.’ largest Specialist R&D tax advisory firms. We manage all facets of the R&D tax credit program, from claim preparation and audit compliance to claim disputes.

Swanson Reed regularly hosts free webinars and provides free IRS CE and CPE credits for CPAs. For more information please visit us at www.swansonreed.com/webinars or contact your usual Swanson Reed representative.

Recent Posts